Schedule 13G ownership disclosure
TRACON PHARMACEUTICALS INC
Security class unavailable · CUSIP: 89237H209
Event date: 2024-01-12
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 2.3000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001096906-24-000504
- Form type
- SC 13G
- Filer
- Tracon Pharmaceuticals, Inc.
- CIK
- CIK 1394319
- Filed
- Mar 19, 2024
- Reporting period
- Jan 12, 2024
- Description
- Schedule 13G beneficial ownership